China’s thalassaemia jab raises hope for common inherited blood disorder
Fast facts
- Category: Asia
- Language: EN
- Published: 2026-04-28 03:31 UTC
- Sources: South China Morning Post
A new jab developed in China aims to provide relief for those suffering from thalassaemia, a common genetic blood disorder. The country has 30 million gene carriers.
Why it matters
- This update can influence the Asia agenda over the next 24-48 hours.
- It is based on 1 source, which helps cross-check key claims quickly.
- Watch follow-up statements and market/public response to assess real impact.